Clinical Trials

 Inclusion Criteria

• Either gender
• Caucasian ethnoracial category
• ≥ 18 years of age
• Has open angles
• Ability to cooperate for visual testing
• Nonprescription and prescription topical ophthalmic products and systemic medications other than those mentioned in the exclusion criteria will be allowed during the study
• Able to participate on site over the multi-visit study period

Exclusion Criteria

• Has narrow angles with complete or partial closure
• Chronic or recurrent inflammatory eye disease
• Ocular trauma within the past 6 months
• Ocular infection or ocular inflammation in the past 3 months
• Clinically significant retinal disease
• Corneal abnormalities interfering with Goldmann tonometry
• Previous intraocular surgery, except uncomplicated cataract extraction
• Recent changes to systemic medications
  • Must be on a stable regimen for at least 30 days prior to visit 1 regarding a chronic systemic medication that may affect IOP (i.e., sympathomimetic agents, beta-blockers, alpha-adrenergic agonists, alpha-adrenergic blockers, calcium channel blockers, angiotensin converting enzyme inhibitors, etc.)